The Role of MicroRNA in Osteoarthritis: Alzheimer's Administrative Supplement
The Role of MicroRNA in Osteoarthritis: Alzheimer's Administrative Supplement
批准号:
10287295
负责人:
Jian Huang
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-10-31
关键词:
APP-PS1Administrative SupplementAdvanced DevelopmentAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmericanAmyloidAmyloidosisAnimal ModelAstrocytesAwarenessBiochemicalBioinformaticsBiological ProcessBrainCOVID-19Cardiovascular DiseasesCaregiversCataractCause of DeathCell AgingCell LineCellsCognitiveDataDegenerative polyarthritisDementiaDeteriorationDiseaseDysplasiaElderlyEmbryoExhibitsExpression ProfilingEyeFunctional disorderGene TargetingGenesGenetic TranscriptionGenotypeHealthHeartHippocampus (Brain)HistologyHomeostasisHumanImmunohistochemistryIn Situ HybridizationInduced pluripotent stem cell derived neuronsInnovative TherapyJointsKnock-outKnockout MiceKnowledgeLightMalignant NeoplasmsMeasuresMelanosisMemory LossMicroRNAsMicrogliaModelingMolecularMusNeuronsOsteoporosisPathogenesisPathologicPatientsPhenotypePlayPremature aging syndromeProteinsQuality of lifeRNARetinal DysplasiaRoleRuptureSenile PlaquesSignal TransductionSkinStainsTherapeuticUnited Statesagedaging populationbrain celldeep sequencingdifferential expressiongene functionhuman old age (65+)innovationinsightloss of functionmiRNA expression profilingmouse modelnovel therapeutic interventionolder patientparent grantpreventpublic health relevancesexskeletalsocioeconomicsthioflavinetranscription factortranscriptome sequencing
中文摘要
项目摘要
阿尔茨海默病(AD)是最常见的与衰老有关的疾病之一,影响超过550万人
65岁及以上的美国人,从而造成巨大的社会经济负担。迄今为止,
AD,由于我们对AD和衰老的生物学过程的了解有限。我们发现,
同源miRNAs,miR-204和miR-211,对于老年关节细胞维持健康的稳态是必需的
以对抗骨关节炎(OA)发病机制。有趣的是,具有双敲除(dKO)的小鼠模型,
miR-204和miR-211显示多种病理变化,大多数与衰老相关,如关节OA,
过熟白内障破裂、葡萄膜黑变病和眼睛中的视网膜发育不良、皮肤中的滤泡发育不良,
和心脏瓣膜性心内膜炎。特别是,加速老化似乎发生在dKO的大脑中,
小鼠因此,dKO小鼠可能代表了一种独特的、全面的衰老模型。的深度测序
miRNAs已经证明miR-204主要在脑中表达,生物信息学分析显示,
miR-204/-211可能靶向多种AD相关基因。考虑到多重老化
在dKO小鼠中,我们假设miR-204和miR-211在脑组织中起重要作用,
病理生理学和miR-204/-211功能丧失可能加剧AD的发病机制。因此我们
在本补充中提出了两个具体目标,以扩大我们在OA和AD中miRNA作用的研究,这两种疾病
涉及衰老的生物过程失调。在目标1中,我们将识别AD相关基因
在目标2中,我们将确定miR-204/-211功能丧失是否与脑细胞中的miR-204/-211靶向相关。
加重AD小鼠模型中的AD发病机制。从这项研究中发现的新见解将加深
我们对AD的理解,揭示了加速衰老是如何发生的,从而推动了
创新的治疗选择,以治疗许多与衰老有关的疾病,包括AD和OA。
英文摘要
Project Summary
Alzheimer’s disease (AD) is one of the most common aging-related diseases, affecting more than 5.5 million
Americans age 65 and older and thus creating enormous socioeconomic burden. To date there is no cure for
AD, due to our limited understanding of AD and biological processes of aging. We have found that two
homologous miRNAs, miR-204 and miR-211, are essential for aged joint cells to maintain healthy homeostasis
to counteract osteoarthritis (OA) pathogenesis. Interestingly, the mouse model with double knockout (dKO) of
miR-204 and miR-211 displayed multiple pathological changes, mostly aging-related, such as OA in joints,
hypermature cataracts with rupture, uveal melanosis, and retinal dysplasia in eyes, follicular dysplasia in skins,
and valvular endocardiosis in hearts. Particularly, accelerated aging appears to occur in the brain of the dKO
mice. Thus, the dKO mice may represent a unique, comprehensive model of aging. Deep sequencing of
miRNAs has demonstrated that miR-204 is dominantly expressed in brain, and bioinformatic analysis reveals
that multiple AD-associated genes may be targeted by miR-204/-211. In consideration of multiplexed aging
phenotypes in the dKO mice, we hypothesize that miR-204 and miR-211 play important roles in brain
pathophysiology and miR-204/-211 loss-of-function may exacerbate the pathogenesis of AD. Thus, we
propose two Specific Aims in this supplement to expand our study of miRNA role in OA on AD, both diseases
involving dysregulation of biological processes of aging. In Aim 1, we will identify AD-associated genes
targeted by miR-204/-211 in brain cells, and in Aim 2, we will determine if miR-204/-211 loss-of-function
exacerbates AD pathogenesis in a mouse model of AD. New insights uncovered from this study will deepen
our understanding of AD and shed light into how accelerated aging occurs, thus advancing the development of
innovative therapeutic options to treat numerous aging-related disorders including AD and OA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia
-
批准号:10545088
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2022
-
负责人:Jian Huang
-
依托单位:
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia
-
批准号:10365005
-
项目类别:
-
资助金额:$52.44万
-
财政年份:2022
-
负责人:Jian Huang
-
依托单位:
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
-
批准号:10363682
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:Jian Huang
-
依托单位:
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
-
批准号:10589119
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:Jian Huang
-
依托单位:
Small-molecule combinationsexpand hematopoietic stem cell ex vivo and in vivo
-
批准号:10018098
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2019
-
负责人:Jian Huang
-
依托单位:
The Role of MicroRNA in Osteoarthritis
-
批准号:9529511
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2017
-
负责人:Jian Huang
-
依托单位:
The Role of MicroRNA in Osteoarthritis
-
批准号:10308475
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2017
-
负责人:Jian Huang
-
依托单位:
The Role of MicroRNA in Osteoarthritis
-
批准号:9736273
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2017
-
负责人:Jian Huang
-
依托单位:
The Role of MicroRNA in Osteoarthritis
-
批准号:10060738
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2017
-
负责人:Jian Huang
-
依托单位:
Signaling pathways regulated by GSK3 in hematopoietic stem cell
-
批准号:8093631
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2011
-
负责人:Jian Huang
-
依托单位:
Signaling pathways regulated by GSK3 in hematopoietic stem cell
-
批准号:8282693
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2011
-
负责人:Jian Huang
-
依托单位:
Signaling pathways regulated by GSK3 in hematopoietic stem cell
-
批准号:8856311
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2011
-
负责人:Jian Huang
-
依托单位:
Signaling pathways regulated by GSK3 in hematopoietic stem cell
-
批准号:8714029
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2011
-
负责人:Jian Huang
-
依托单位:
Signaling pathways regulated by GSK3 in hematopoietic stem cell
-
批准号:8641744
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2011
-
负责人:Jian Huang
-
依托单位:
海外基金